Comparison
20q11 2 Microduplication Syndrome C4706257 vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 20q11 2 Microduplication Syndrome and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
20q11 2 Microduplication Syndrome C4706257
A rare genetic condition involving extra genetic material on chromosome 20. It can lead to developmental delays, speech issues, and various health concerns. Treatment is tailored to each person's specific needs.
11p15 4 Microduplication Syndrome C4749508
A rare genetic disorder involving duplication of material on chromosome 11, leading to varied developmental features. Requires individualized medical assessment.
6 comparison axes
Onset
20q11 2 Microduplication Syndrome C4706257
0-null
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
20q11 2 Microduplication Syndrome C4706257
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
20q11 2 Microduplication Syndrome C4706257
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
20q11 2 Microduplication Syndrome C4706257
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
20q11 2 Microduplication Syndrome C4706257
congenital
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
20q11 2 Microduplication Syndrome C4706257
rare-disease
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
20q11-2-microduplication-syndrome-C4706257 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 20q11 2 Microduplication Syndrome C4706257 | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Developmental delay | Reported in some people; severity and domains vary. | Varied developmental features are described, but a typical pattern is not established. | Low |
| Speech difficulty | Speech issues are mentioned, without a defining profile. | Speech involvement is not specifically established from the supplied data. | Low |
| Chromosomal locus | Extra material involves 20q11.2. | Duplicated material involves 11p15.4. | High |
When to favor each condition
Choose 20q11 2 Microduplication Syndrome C4706257 when
Confirmed extra material at 20q11.2
The locus identifies this condition rather than clinical appearance.
High
Developmental or speech concerns with a matching result
These concerns may prompt testing but do not independently establish the diagnosis.
Moderate
Need for individualized congenital-care planning
Source data describe varied health concerns and support needs.
Low
Choose 11p15 4 Microduplication Syndrome C4749508 when
Confirmed duplication at 11p15.4
Laboratory localization is the decisive distinction.
High
Varied developmental features without a defined syndrome pattern
This fits the sparse description but is not diagnostic alone.
Low
Planning assessment when severity appears moderate
The supplied severity label is moderate, although individual outcomes are not established.
Low
How key tests differ
| Test | 20q11 2 Microduplication Syndrome C4706257 | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number gain involving 20q11.2. | Copy-number gain involving 11p15.4. | The genomic coordinates distinguish the findings; size and gene content need laboratory reporting. |
| Karyotype | May miss a small duplication. | May also miss a small duplication. | A normal karyotype does not exclude either condition. |
| Targeted confirmation | Confirms the chromosome 20 finding when appropriate. | Confirms the chromosome 11 finding when appropriate. | Use the method recommended by the reporting laboratory; no cutoff is established here. |
Prognosis comparison
20q11 2 Microduplication Syndrome C4706257
- Outcome
- Long-term outcome is not established; the source labels severity as severe.
- Factors
- Duplication content, associated findings, and available support may influence needs.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- Long-term outcome is not established; the source labels severity as moderate.
- Factors
- Individual developmental profile and medical findings matter more than the label.
Time frame: Often congenital and chronic, but course is not defined here.
No mortality or universal prognosis can be inferred from the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Delays and speech issues are reported in some cases. Developmental features vary and are not fully defined. Neither complication profile is established from these sparse descriptions. |
| Associated health concerns | Various concerns may occur, without a fixed list. Associated problems are not specified in the source. Clinicians should assess each person rather than assume complications. |
| Inheritance or recurrence | Not established by the supplied data. Not established by the supplied data. Genetic counseling can interpret parental testing and recurrence. |
Patient education highlights
- HighDiagnosis
A duplication result is a genetic finding; its clinical meaning requires specialist interpretation.
- HighCare
Support is individualized and may include developmental, speech, and medical follow-up.
- MediumLimits of knowledge
These descriptions do not establish exact symptoms, prognosis, prevalence, or treatment doses.